Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Poll|May 11, 2022

Poll results: Are you attending Retina World Congress 2022?

Author(s)Emily Kaiser Maharjan

Results from our recent poll regarding Retina World Congress 2022 attendance indicate that while many retina specialists will attend the Congress, the majority will not be in Fort Lauderdale, Florida.

Modern Retina® polled our audience with the following question from April 30, 2022 to May 9, 2022: Are you attending Retina World Congress 2022?

The poll appeared on modernretina.com and was promoted on Twitter, Facebook, and LinkedIn. Results show a majority of ophthalmologists plan to skip Retina World Congress this year.

14 responses were recorded, in total. Of these:

• 43% responded "Yes, I will be in Fort Lauderdale."

• 57% responded "No, I will not be attending this year."

Newsletter

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Related Content

Suprachoroidal space injection for the treatment of noninfectious uveitis

BySteven Yeh, MD, FASRS

July 22nd 2026

Cynthia Toth, MD, of the Duke Department of Ophthalmology

Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MD

ByCytnthia Toth, MD,Lucia Gambuzza,Abigail Lewis, Content Intern

July 8th 2026

(Modern Retina) Vaccinated patients show markedly lower risk of new-onset idiopathic uveitis

Vaccinated patients show markedly lower risk of new-onset idiopathic uveitis

ByModern Retina Staff

July 3rd 2026

Detecting peripheral retinal lesions in children with myopia

ByJacques Bijon, MD,Thibaut Chapron, MD, PhD

July 1st 2026

Digital mindfulness app reduces anxiety, depression in uveitis

Digital mindfulness app reduces anxiety, depression in uveitis

ByModern Retina Staff

June 27th 2026

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Treatment Optimization in the Evolving Anti-VEGF Era

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD

Trending on Eye Care Network - Ophthalmology Times

Comments from the FDA Advisory Committee meeting on SYD-101

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

FAQ: Diabetic eye disease awareness month 2026

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Mediterranean diet linked to slower AMD progression across stages